![Daniel Thiel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel Thiel
Corporate Officer/Principal chez NanoSmart Pharmaceuticals, Inc.
Profil
Daniel Thiel currently works as a Vice President of Business Development at NanoSmart Pharmaceuticals, Inc.
Postes actifs de Daniel Thiel
Sociétés | Poste | Début |
---|---|---|
NanoSmart Pharmaceuticals, Inc.
![]() NanoSmart Pharmaceuticals, Inc. BiotechnologyHealth Technology NanoSmart Pharmaceuticals, Inc. is a privately-held corporation based in Laguna Hills, CA. The private company is developing nanoparticle drug delivery platforms, including utilization of anti-nuclear antibody (ANA) to enable targeted drug delivery of existing drug therapies to areas of necrosis present in virtually all solid cancer tumors. Henry J. Smith has been the CEO of the company since 2006. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
NanoSmart Pharmaceuticals, Inc.
![]() NanoSmart Pharmaceuticals, Inc. BiotechnologyHealth Technology NanoSmart Pharmaceuticals, Inc. is a privately-held corporation based in Laguna Hills, CA. The private company is developing nanoparticle drug delivery platforms, including utilization of anti-nuclear antibody (ANA) to enable targeted drug delivery of existing drug therapies to areas of necrosis present in virtually all solid cancer tumors. Henry J. Smith has been the CEO of the company since 2006. | Health Technology |